Transamerica Financial Advisors, LLC
Position in JNJ — Johnson & Johnson
CIK 1502149
CEDAR RAPIDS, IA
Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,902,235
-$100,706 QoQ
Shares Held
7,490
-8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,398
of 4,664 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $18,529,171 across 15 Drug Manufacturers - General names. JNJ ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,030 | $6,033,133 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,868 | $2,167,538 | |
| 3 | ABBV |
AbbVie Inc.
|
8,498 | $2,138,436 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
7,490 | $1,902,235 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,368 | $1,815,253 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,390 | $1,520,591 | |
| 7 | SNY |
Sanofi
|
14,570 | $621,556 | |
| 8 | AZN |
Astrazeneca PLC
|
3,264 | $618,919 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,902,235 | 7,490 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $2,002,941 | 8,194 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,895,868 | 9,161 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,898,144 | 10,237 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,558,355 | 10,202 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,752,762 | 10,569 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,620,322 | 11,204 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,694,823 | 10,458 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $548,100 | 3,750 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $593,212 | 3,750 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $607,994 | 3,879 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $746,665 | 4,794 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,961,577 | 11,851 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,930,835 | 12,457 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,993,141 | 11,283 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,635,070 | 10,009 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,489,308 | 8,390 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $886 | 5 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $855 | 5 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $807 | 5 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $823 | 5 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $657 | 4 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $629 | 4 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,042 | 7 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $271,978 | 1,934 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||